Search - tctmd.com

Displaying 321 - 340 of 414

Sort: Relevancy | Date

Presentation TCT Russia 2013

LAA Closure Devices - Technique Description and Emerging Data

Presenter: Horst Sievert

June 09, 2013

Presentation

An Economic Evaluation of Percutaneous LAA Occlusion

Presenter: Sheldon M. Singh

June 04, 2013

Presentation

Percutaneous LAA Closure with the Amplatzer Cardiac Plug in Patients with Nonvalvular A-fib and Contraindications for Anticoagulation Therapy

Presenter: M. Urena

May 28, 2013

Presentation

PROTECT AF: The Mortality Effects of LAA Closure vs. Warfarin for Stroke Prophylaxis in A-fib

Presenter: Vivek Y. Reddy

May 14, 2013

Presentation Fellows 2013

LAA Closure for Nonvalvular Atrial Fibrillation

Presenter: Mark Reisman

April 17, 2013

Presentation

LAA Closure with the Watchman Device in Patients with a Contraindication for Oral Anticoagulation

Presenter: Vivek Y. Reddy

April 09, 2013

Presentation ECHO 2013

Quantifying the Left Heart (LV and LA): Basic and Advanced Measurements

Presenter: Omar Khalique

April 03, 2013

Presentation

Post ACC Wrap-up: PREVAIL and PARTNER II

Presenter: Gregg W. Stone

March 13, 2013

Presentation ACC 2013

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Presenter: David R. Holmes, Jr.

March 08, 2013

Presentation

Quality-of-Life Assessment in the Randomized PROTECT AF Trial of Patients at Risk for Stroke with Nonvalvular A-fib

Presenter: 147572|Oluseun Alli

February 27, 2013

Presentation TCT 2013

Safety and Biocompatibility of the Coherex WaveCrest[sup]TM[/sup] Left Atrial Appendage Occluder in a 30-Day Canine Study

Presenter: Yanping Cheng, Jenn McGregor, Robert Sommer, William Gray, Daryl Edmiston, Gerard Conditt, Genghua Yi, Armando Tellez, Serge Rousselle, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Impact of left atrial appendage occlusion, with percutaneous device on left atrial function

Presenter: Pedro Almeida, Eduardo Infante de Oliveira, Jo?o Marques, Fernando Ribeiro, Pedro Canas Silva, Ant?nio Nunes Diogo, Fausto Pinto

January 31, 2013

Presentation TCT 2013

First In-Vivo Evaluation of the Ultrasept Left Atrial Appendage Closure Device

Presenter: Yanping Cheng, Gerard Conditt, Genghua Yi, Alyssa Wagner, Patricia Mount, Armando Tellez, Serge Rousselle, Greg Kaluza, Juan Granada

January 31, 2013

Presentation TCT 2013

Early Safety of the Amplatzer Cardiac Plug™ for Left Atrial Appendage Occlusion

Presenter: David Meerkin, Adi Butnaru, Dmitry Dratva, Olivier Bertrand, Dan Tzivoni

January 31, 2013

Presentation TCT 2013

Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared With 5 Alternative Anticoagulation Strategies For Stroke Prevention In Atrial Fibrillation: A Markov...

Presenter: Bryan Yan, Chow Innes, Yat Yin Lam, Vivian Lee, Cheuk Man Yu

January 31, 2013

Presentation

Percutaneous Left Atrial Appendage (LAA) Closure for Stroke Prophylaxis in A-fib Patients

Presenter: Vivek Y. Reddy

January 29, 2013

Presentation

Initial Experience with a Novel Percutaneous LAA Exclusion Device in Pts with A-fib, Increased Stroke Risk, and Contraindications to Anticoagulation

Presenter: A. Massumi

January 14, 2013

Presentation TCT 2012

Will Transcatheter Left Atrial Appendage Closure Transform Management of Atrial Fibrillation?

Presenter: Vivek Reddy

October 25, 2012

Presentation TCT 2012

Promising LAA Closure Devices and the Structural Heart Team Approach

Presenter: Carlos Pedra

October 25, 2012

Presentation TCT 2012

Transcatheter LAA Occlusion: The Watchman Experience as Proof of Principle

Presenter: David Muller

October 24, 2012

Advertisement

LAA Closure Devices - Technique Description and Emerging Data

An Economic Evaluation of Percutaneous LAA Occlusion

Percutaneous LAA Closure with the Amplatzer Cardiac Plug in Patients with Nonvalvular A-fib and Contraindications for Anticoagulation Therapy

PROTECT AF: The Mortality Effects of LAA Closure vs. Warfarin for Stroke Prophylaxis in A-fib

LAA Closure for Nonvalvular Atrial Fibrillation

LAA Closure with the Watchman Device in Patients with a Contraindication for Oral Anticoagulation

Quantifying the Left Heart (LV and LA): Basic and Advanced Measurements

Post ACC Wrap-up: PREVAIL and PARTNER II

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Quality-of-Life Assessment in the Randomized PROTECT AF Trial of Patients at Risk for Stroke with Nonvalvular A-fib

Safety and Biocompatibility of the Coherex WaveCrest[sup]TM[/sup] Left Atrial Appendage Occluder in a 30-Day Canine Study

Impact of left atrial appendage occlusion, with percutaneous device on left atrial function

First In-Vivo Evaluation of the Ultrasept Left Atrial Appendage Closure Device

Early Safety of the Amplatzer Cardiac Plug™ for Left Atrial Appendage Occlusion

Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared With 5 Alternative Anticoagulation Strategies For Stroke Prevention In Atrial Fibrillation: A Markov...

Percutaneous Left Atrial Appendage (LAA) Closure for Stroke Prophylaxis in A-fib Patients

Initial Experience with a Novel Percutaneous LAA Exclusion Device in Pts with A-fib, Increased Stroke Risk, and Contraindications to Anticoagulation

Will Transcatheter Left Atrial Appendage Closure Transform Management of Atrial Fibrillation?

Promising LAA Closure Devices and the Structural Heart Team Approach

Transcatheter LAA Occlusion: The Watchman Experience as Proof of Principle

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content